Filament Health Corp (FH) - Net Assets

Latest as of March 2025: CA$974.38K CAD ≈ $704.85K USD

Based on the latest financial reports, Filament Health Corp (FH) has net assets worth CA$974.38K CAD (≈ $704.85K USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$2.91 Million ≈ $2.11 Million USD) and total liabilities (CA$1.94 Million ≈ $1.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read FH current and long-term liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$974.38K
% of Total Assets	33.47%
Annual Growth Rate	21.05%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	857.04

Filament Health Corp - Net Assets Trend (2020–2024)

This chart illustrates how Filament Health Corp's net assets have evolved over time, based on quarterly financial data. Also explore Filament Health Corp (FH) total assets for the complete picture of this company's asset base.

Annual Net Assets for Filament Health Corp (2020–2024)

The table below shows the annual net assets of Filament Health Corp from 2020 to 2024. For live valuation and market cap data, see Filament Health Corp stock valuation.

Year	Net Assets	Change
2024-12-31	CA$1.75 Million ≈ $1.26 Million	-29.87%
2023-12-31	CA$2.49 Million ≈ $1.80 Million	-21.98%
2022-12-31	CA$3.19 Million ≈ $2.31 Million	-80.71%
2021-12-31	CA$16.55 Million ≈ $11.97 Million	+1934.37%
2020-12-31	CA$813.64K ≈ $588.58K	--

Equity Component Analysis

This analysis shows how different components contribute to Filament Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3600927700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Other Components	CA$37.87 Million	2167.29%
Total Equity	CA$1.75 Million	100.00%

Filament Health Corp Competitors by Market Cap

The table below lists competitors of Filament Health Corp ranked by their market capitalization.

Company	Market Cap
RBR Group Ltd AU:RBR	$1.89 Million
Radaan Mediaworks India Limited NSE:RADAAN	$1.90 Million
L Agence Automobiliere SA PA:MLAA	$1.90 Million
DMC Mining Ltd AU:DMM	$1.90 Million
KINGS ENTERTAINMENT GROUP F:L12	$1.89 Million
Young & Co.'s Brewery P.L.C LSE:YNGN	$1.89 Million
BT Wealth Industries Public Company Limited BK:BTW	$1.89 Million
Silly Monks Entertainment Limited NSE:SILLYMONKS	$1.89 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Filament Health Corp's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 2,491,569 to 1,747,248, a change of -744,321 (-29.9%).
Net loss of 4,970,272 reduced equity.
New share issuances of 135,000 increased equity.
Other factors increased equity by 4,090,951.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-4.97 Million	-284.46%
Share Issuances	CA$135.00K	+7.73%
Other Changes	CA$4.09 Million	+234.14%
Total Change	CA$-	-29.87%

Book Value vs Market Value Analysis

This analysis compares Filament Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.50x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 2.02x to 1.50x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2020-12-31	CA$0.00	CA$0.01	x
2021-12-31	CA$0.10	CA$0.01	x
2022-12-31	CA$0.02	CA$0.01	x
2023-12-31	CA$0.01	CA$0.01	x
2024-12-31	CA$0.01	CA$0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Filament Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -284.46%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -805.98%
• Asset Turnover: 0.18x
• Equity Multiplier: 1.95x
Recent ROE (-284.46%) is below the historical average (-267.41%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2021	-55.90%	-5694.53%	0.01x	1.08x	CA$-10.91 Million
2022	-515.65%	-4517.55%	0.08x	1.48x	CA$-16.79 Million
2023	-213.60%	-249.75%	0.38x	2.24x	CA$-5.57 Million
2024	-284.46%	-805.98%	0.18x	1.95x	CA$-5.14 Million

Industry Comparison

This section compares Filament Health Corp's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Filament Health Corp (FH)	CA$974.38K	-55.90%	1.99x	$1.89 Million
Economic Investment Trust Ltd (EVT)	$1.10 Billion	19.29%	0.09x	$94.65 Million
Noble Mineral Exploration Inc (NOB)	$-132.16K	0.00%	0.00x	$8.46 Million
Quorum Information Technologies Inc (QIS)	$8.32 Million	-12.56%	0.07x	$42.09 Million

About Filament Health Corp

NEO:FH Canada

Market Cap

$1.89 Million

CA$2.62 Million CAD

Market Cap Rank

#29743 Global

#1508 in Canada

Share Price

CA$0.01

Change (1 day)

-33.33%

52-Week Range

CA$0.01 - CA$0.03

All Time High

CA$0.40